- Capital Cube•28 days ago
Click here to see latest analysisBioStar Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of BioStar Pharmaceuticals, Inc. – Nature’s Sunshine Products, Inc., Emisphere Technologies, Inc., ProPhase Labs, Inc. and USANA Health Sciences, Inc. (NATR-US, EMIS-US, PRPH-US and USNA-US) that have also reported […] (Read more...) The post BioStar Pharmaceuticals, Inc. :BSPM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 appeared first on CapitalCube.
- Insider Monkey•last month
Markets are getting hammered as the shocked investors react to the UK’s decision to bid farewell to the European Union. International markets have started to feel the heat and immediate ramifications of the referendum’s results after which the UK is set to embark on a road teeming with uncertainties. Investors are also closely watching some […]
Biostar Pharmaceuticals, Inc.NasdaqCM
After hours: 4.40-0.05 (-1.12%) as of 5:36 PM EDT
|Bid||4.39 x 500|
|Ask||4.53 x 1100|
|52wk Range||1.08 - 6.59|
|Day's Range||4.00 - 5.35|
|Avg Vol (3m)||1,041,801|
As of 4:00 PM EDT. Market closed.